Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

RDA Recommended Dietary AllowancesCorrelations of DTAC with nutrient intakes and food groupsVariableCases (n = 34)r/pControls (n = 34)r/pMacronutrients and Micronutrients Energy (kcal/day)0.331/0.028−0.123/0.240 Carbohydrate (g/day)0.241/0.0850.034/0.424 Carbohydrate (% energy)−0.183/0.150−0.018/0.460 Protein (g/day)0.464/0.003**0.111/0.263 Protein (% energy)0.296/0.044*0.150/0.195 Fat (% energy)0.134/0.225−0.016/0.463 Saturated fatty acids (%)−0.146/0.2050.156/0.186 Linoleic acid (% energy)−0.138/0.2190.033/0.425 Alpha-linolenic acid (% energy)−0.075/0.3370.036/0.419 Fiber (g/day)0.134/0.2240.160/0.180 Calcium (mg/day)−0.402/0.009**−0.155/0.187 Iron (mg/day)0.146/0.204−0.120/0.249 Magnesium (mg/day)0.026/0.4420.026/0.441 Phosphorus (mg/day)0.103/0.2820.132/0.225 Potassium (mg/day)0.159/0.184−0.159/0.181 Sodium (mg/day)0.021/0.453−0.055/0.378 Zinc (mg/day)−0.051/0.3870.017/0.462 Copper (mg/day)0.162/0.180−0.314/0.033* Vitamin A (µg RE/day)0.162/0.1800.068/0.350 Vitamin D (µg/day)−0.052/0.3840.120/0.246 Vitamin E (mg/day)0.414/0.007**−0.070/0.344 Vitamin K (µg/day)0.087/0.3120.151/0.193 Vitamin C (mg/day)0.242/0.0840.123/0.241 Thiamin (mg/day)0.200/0.129−0.043/0.402 Riboflavin (mg/day)−0.001/0.497−0.150/0.194 Vitamin B6 (mg/day)−0.168/0.1720.006/0.486 Vitamin B12 (µg/day)−0.129/0.2330.058/0.370 Folate (µg/day)−0.001/0.498−0.088/0.308 Niacin (mg NE/day)0.125/0.2410.214/0.108Food Groups Milk (g/day)0.013/0.471−0.145/0.203 Yogurt (g/day)0.131/0.2310.076/0.333 Cheese (g/day)0.187/0.1440.315/0.033 Red meat (g/day)−0.142/0.212−0.152/0.192 Poultry (g/day)0.100/0.287−0.041/0.408 Fish and seafood (g/day)−0.012/0.4740.174/0.159 Organ meats (g/day)0.239/0.086−0.093/0.298 Processed meat (g/day)0.182/0.1520.104/0.276 Eggs (g/day)0.279/0.0550.373/0.014* Legumes (g/day)0.288/0.049*0.074/0.337 Green vegetables (g/day)0.458/0.003**0.571/≤ 0.001** Vegetables (g/day)0.520/0.001**0.632/≤ 0.001** Citrus fruits (g/day)0.432/0.005*0.206/0.118 Fresh fruits (g/day)0.347/0.0220.535/≤ 0.001** Fruit juice (ml/day)0.331/0.0280.210/0.113 White bread (g/day)−0.165/0.176−0.132/0.225 Whole grain bread (g/day)0.580/≤ 0.001**0.391/0.010* Rice, bulgur, pasta (g/day)0.197/0.131−0.018/0.458 Cakes, pastries, biscuits (g/day)−0.246/0.0800.081/0.323 Olive oil (g/day)0.296/0.045*0.196/0.129 Sunflower oil (g/day)0.069/0.349−0.217/0.105 Margarine (g/day)0.193/0.137−0.135/0.219 Olives (g/day)0.253/0.0750.247/0.076 Butter (g/day)0.088/0.3100.311/0.035* Packaged fruit juice (g/day)−0.081/0.325−0.273/0.056 Nuts (g/day)0.292/0.047*0.408/0.007* Honey, jam, molasses (g/day)−0.236/0.089−0.062/0.362 Coffee (ml/day)0.719/≤ 0.0001**0.258/0.067 Black tea (ml/day)0.099/0.2890.472/0.002* Herbal tea (ml/day)0.360/0.018*0.135/0.220 Soft drinks (ml/day)0.183/0.150−0.170/0.165 Alcohol (ml/day)−0.008/0.482−0.039/0.412DTAC Dietary total antioxidant capacity, *Spearman correlation analysis. *p < 0.05, **p < 0.01

Source: Dietary total antioxidant capacity (DTAC) and dietary diversity. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Case-control study.

Case-control study

Compares people with an outcome against people without it, examining exposures.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Nutritional status, dietary antioxidant capacity, and dietary diversity in patients with newly diagnosed hematological malignancies: a case: control study

Source: Article title.

Participants were eligible if they could undergo bioelectrical impedance analysis (BIA), were literate, and provided informed consent.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Nutritional status, dietary antioxidant capacity, and dietary diversity in patients with newly diagnosed hematological malignancies: a case-control study

Case-control study · Supportive Care in Cancer · 2026

Original publication title

Nutritional status, dietary antioxidant capacity, and dietary diversity in patients with newly diagnosed hematological malignancies: a case: control study

Busra Nur Koyuncu; Merve Yilmaz; Fatos Dilan Koseoglu

© The Author(s) 2026

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Significant differences in nutritional status and DTAC between patients and healthy individuals suggest that suboptimal dietary patterns may accompany hematological malignancies at diagnosis. These findings highlight the potential importance of adequate macro: and micronutrient intake; however, further prospective studies are needed to determine whether targeted nutritional interventions can improve clinical outcomes or contribute to long-term risk reduction.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

Nutritional status and dietary antioxidant capacity are important determinants of clinical resilience in cancer; however, data in hematological malignancies remain limited. We aimed to compare nutritional status, dietary total antioxidant capacity (DTAC), and dietary diversity between patients with newly diagnosed hematological malignancies and healthy controls.

Source: Purpose

Abstract: What methods does the paper describe?

This case: control study included 34 patients with newly diagnosed hematological malignancies (12 lymphoma, 11 leukaemia, 11 multiple myeloma) and 34 age: and sex-matched healthy controls aged 18 to 65 years. DTAC was estimated using the ferric reducing antioxidant power (FRAP) method based on a validated food frequency questionnaire. Nutrient intakes and the dietary diversity score (DDS) were derived from 3-day dietary records. Nutritional status was assessed using the Global Leadership Initiative on Malnutrition (GLIM) criteria, along with fat-free mass index (FFMI), and mid-upper arm circumference (MUAC).

Source: Methods

Abstract: Results

Patients had significantly lower DTAC levels than controls (3.85 ± 1.58 vs. 8.68 ± 3.21 mmol/day, p < 0.05). According to GLIM criteria, 35.3% of patients had moderate malnutrition and 26.5% had severe malnutrition, A declining trend in DTAC was observed with worsening malnutrition (p = 0.034), although this did not reach the significance threshold after multiplicity adjustment. Low muscle mass was more prevalent in patients as assessed by both FFMI and MUAC. Energy, protein, zinc, vitamin E, and folate intakes were significantly lower in patients (all p < 0.05), whereas DDS did not differ (p > 0.05).

DTAC was positively correlated with intakes of coffee, whole-grain bread, green vegetables, citrus fruits, and fresh fruit (p ≤ 0.05).

Source: Results

Abstract: Conclusions

Significant differences in nutritional status and DTAC between patients and healthy individuals suggest that suboptimal dietary patterns may accompany hematological malignancies at diagnosis. These findings highlight the potential importance of adequate macro: and micronutrient intake; however, further prospective studies are needed to determine whether targeted nutritional interventions can improve clinical outcomes or contribute to long-term risk reduction.

Source: Conclusions
Authors’ abstract

Purpose

Nutritional status and dietary antioxidant capacity are important determinants of clinical resilience in cancer; however, data in hematological malignancies remain limited. We aimed to compare nutritional status, dietary total antioxidant capacity (DTAC), and dietary diversity between patients with newly diagnosed hematological malignancies and healthy controls.

Methods

This case: control study included 34 patients with newly diagnosed hematological malignancies (12 lymphoma, 11 leukaemia, 11 multiple myeloma) and 34 age: and sex-matched healthy controls aged 18 to 65 years. DTAC was estimated using the ferric reducing antioxidant power (FRAP) method based on a validated food frequency questionnaire. Nutrient intakes and the dietary diversity score (DDS) were derived from 3-day dietary records. Nutritional status was assessed using the Global Leadership Initiative on Malnutrition (GLIM) criteria, along with fat-free mass index (FFMI), and mid-upper arm circumference (MUAC).

Results

Patients had significantly lower DTAC levels than controls (3.85 ± 1.58 vs. 8.68 ± 3.21 mmol/day, p < 0.05). According to GLIM criteria, 35.3% of patients had moderate malnutrition and 26.5% had severe malnutrition, A declining trend in DTAC was observed with worsening malnutrition (p = 0.034), although this did not reach the significance threshold after multiplicity adjustment. Low muscle mass was more prevalent in patients as assessed by both FFMI and MUAC. Energy, protein, zinc, vitamin E, and folate intakes were significantly lower in patients (all p < 0.05), whereas DDS did not differ (p > 0.05).

DTAC was positively correlated with intakes of coffee, whole-grain bread, green vegetables, citrus fruits, and fresh fruit (p ≤ 0.05).

Conclusions

Significant differences in nutritional status and DTAC between patients and healthy individuals suggest that suboptimal dietary patterns may accompany hematological malignancies at diagnosis. These findings highlight the potential importance of adequate macro: and micronutrient intake; however, further prospective studies are needed to determine whether targeted nutritional interventions can improve clinical outcomes or contribute to long-term risk reduction.

Publication and source details

Original title: Nutritional status, dietary antioxidant capacity, and dietary diversity in patients with newly diagnosed hematological malignancies: a case: control study

Busra Nur Koyuncu; Merve Yilmaz; Fatos Dilan Koseoglu

Supportive Care in Cancer · 2026

© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Izmir Tinaztepe University

Open access funding provided by the Scientific and Technological Research Council of Türkiye (TÜBİTAK).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:22:38.897247+00:00

DOI: 10.1007/s00520-026-10817-5 · PMC13230294